McKesson Corporation MCK
866.64
(2.72)
(0.31%)
as of 25 Sep
- Market cap
- $101.8B
- P/E
- 23.1×
Follow MCK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
McKesson Corporation (MCK) P/B ratio
McKesson Corporation has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (September 2026) to 186× (May 2021) — the current reading is the lowest in ten years.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 179× | 3,790.09% |
| FY2020 | 4.6× | 63.45% |
| FY2019 | 2.8× | (2.65%) |
| FY2018 | 2.9× | (0.51%) |
| FY2017 | 2.9× | (27.61%) |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 186×
Ten-year median
2.6×
Current reading's percentile
47
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| MCK McKesson Corporation | n/m |
| ACH Accendra Health, Inc. compare | n/m |
| CAH Cardinal Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | 0.1× |
| COSM Cosmos Health Inc. compare | 1.0× |
| HSIC Henry Schein, Inc. compare | 2.6× |
| COR Cencora, Inc. compare | 18.3× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on MCK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement